Adeno-associated virus (AAV) has emerged as a highly promising vector for human gene therapy due to its favorable safety profile, versatility, and ability to transduce a wide range of tissues. However, natural AAV serotypes have shortcomings, including suboptimal transduction efficiency, pre-existing immunity, and a lack of tissue specificity, that hinder their therapeutic potential. To address these challenges, significant efforts are being applied to engineer novel AAV capsids.

The following table contain a list of RepCap plasmid (encoding AAV Rep and respective capsid protein which determines the AAV serotype) that are useful to produce natural or engineered novel AAV. You can search or sort this table based on plasmid name, species, gene name and order the RepCap plasmid immediately.

Check out our Pre-made AAV and learn about our options for hundreds of in-stock preps that are ready to ship right away, as well as our AAV Production Service to give you more flexibility.